Childhood cancers: open trials in South Korea

• NCT05384626

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  Trial Treatment · Phase 1/2 · Nuvalent Inc.

  National Cancer Center, Goyang-si · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-06

• NCT05862285

  A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  National Cancer Center, Goyang-si · CHA Bundang Medical Center, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-11-06

• NCT05533775

  A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

  Trial Treatment · Phase 1/2 · Hoffmann-La Roche

  Seoul National University Hospital- Pediatric Site, Seoul · Asan Medical Center, Seoul

  Registry updated 2026-11-05

• NCT04811560

  A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

  Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC

  Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-11-04

• NCT04924075

  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Seoul National University Hospital (Site 2001), Jongno-gu · Asan Medical Center (Site 2000), Songpa-gu

  Registry updated 2026-11-03

• NCT03435796

  Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  Trial Treatment · Phase 2/3 · Celgene

  The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center (AMC), Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-02

• NCT07911267

  Development and Utilization of an Integrated Clinical Genomic Database

  Research · Samsung Medical Center

  Samsung Medical Center, Seoul

  Registry updated 2026-11-02

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Asan Medical Center-Pediatrics - Pedicatric Oncology (Site 1973), Seoul · Seoul National University Hospital-Pediatrics (Site 1972), Seoul

  Registry updated 2026-10-30

• NCT07630974

  A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Asan Medical Center-Pediatrics - Pedicatric Oncology (Site 4973), Seoul · Seoul National University Hospital-Pediatrics (Site 4972), Seoul

  Registry updated 2026-10-30

• NCT07700758

  A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  Seoul National University Hospital-Pediatrics (Site 5972), Seoul · Asan Medical Center-Pediatrics - Pedicatric Oncology (Site 5973), Seoul

  Registry updated 2026-10-30

• NCT07155226

  Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-23

• NCT06902545

  A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

  Research · Astellas Pharma Korea, Inc.

  Daejeon · Goyang-si · Hwasun Gun · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Suwon · Suwon · Uijeongbu-si · Yangsan

  Registry updated 2026-10-22

• NCT07211958

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Trial Treatment · Phase 3 · Syndax Pharmaceuticals

  Busan · Daegu · Goyang-si · Seoul

  Registry updated 2026-10-21

• NCT06011954

  A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

  Research · Astellas Pharma Korea, Inc.

  Busan · Busan · Busan · Busan · Daegu · Daejeon · Goyang-si · Incheon · Jeollanam-do · Jeonju · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Suwon · Suwon

  Registry updated 2026-10-20

• NCT07878364

  Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study

  Research · MedPacto, Inc.

  National Cancer Center, Goyang-si · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Korea Cancer Center Hospital, Seoul

  Registry updated 2026-10-16

• NCT07109219

  Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-15

• NCT07354074

  Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Seoul

  Registry updated 2026-10-15

• NCT07387926

  Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Seoul

  Registry updated 2026-10-15

• NCT04566380

  ONO-4538 Phase II Rollover Study (ONO-4538-98)

  Trial Treatment · Phase 2 · Ono Pharmaceutical Co., Ltd.

  Daegu · Daegu · Daegu · Gyeonggi-do · Hwasun · Incheon · Seoul · Seoul · Seoul · Seoul · Seoul · Seoul · Suwon

  Registry updated 2026-10-14

• NCT06137118

  AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-13

• NCT06137144

  AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-13

• NCT07032103

  Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

  Research · Samsung Medical Center

  Samsung Medical Center, Seoul

  Registry updated 2026-10-13

• NCT05588648

  Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma

  Trial Treatment · Phase 1/2 · MedPacto, Inc.

  Seoul National University Bundang Hospital, Gyeonggi-do · National Cancer Center, Gyeonggi-do · Korea Institute of Radiological & Medical Sciences, Seoul · Samsung Medical Center, Seoul · Seoul ASAN Medical Center, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-10-07

• NCT06590857

  Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

  Trial Treatment · Phase 1/2 · RayzeBio, Inc.

  Seoul

  Registry updated 2026-10-06

• NCT06697301

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  Trial Treatment · Phase 2/3 · Eikon Therapeutics

  Kyungpook National University Chilgok Hospital, Daegu · Seoul National University Hospital, Seoul

  Registry updated 2026-10-06

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error